1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antibody-drug Conjugates Revenue
1.4 Market Analysis by Type
1.4.1 Global Antibody-drug Conjugates Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Adcetris
1.4.3 Kadcyla
1.5 Market by Application
1.5.1 Global Antibody-drug Conjugates Market Share by Application: 2021-2026
1.5.2 Breast Cancer
1.5.3 Lymphoma
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Antibody-drug Conjugates Market
1.8.1 Global Antibody-drug Conjugates Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Antibody-drug Conjugates Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Antibody-drug Conjugates Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Antibody-drug Conjugates Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Antibody-drug Conjugates Sales Volume Market Share by Region (2015-2020)
3.2 Global Antibody-drug Conjugates Sales Revenue Market Share by Region (2015-2020)
3.3 North America Antibody-drug Conjugates Sales Volume
3.3.1 North America Antibody-drug Conjugates Sales Volume Growth Rate (2015-2020)
3.3.2 North America Antibody-drug Conjugates Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Antibody-drug Conjugates Sales Volume
3.4.1 East Asia Antibody-drug Conjugates Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Antibody-drug Conjugates Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Antibody-drug Conjugates Sales Volume (2015-2020)
3.5.1 Europe Antibody-drug Conjugates Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Antibody-drug Conjugates Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Antibody-drug Conjugates Sales Volume (2015-2020)
3.6.1 South Asia Antibody-drug Conjugates Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Antibody-drug Conjugates Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Antibody-drug Conjugates Sales Volume (2015-2020)
3.7.1 Southeast Asia Antibody-drug Conjugates Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Antibody-drug Conjugates Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Antibody-drug Conjugates Sales Volume (2015-2020)
3.8.1 Middle East Antibody-drug Conjugates Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Antibody-drug Conjugates Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Antibody-drug Conjugates Sales Volume (2015-2020)
3.9.1 Africa Antibody-drug Conjugates Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Antibody-drug Conjugates Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Antibody-drug Conjugates Sales Volume (2015-2020)
3.10.1 Oceania Antibody-drug Conjugates Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Antibody-drug Conjugates Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Antibody-drug Conjugates Sales Volume (2015-2020)
3.11.1 South America Antibody-drug Conjugates Sales Volume Growth Rate (2015-2020)
3.11.2 South America Antibody-drug Conjugates Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Antibody-drug Conjugates Sales Volume (2015-2020)
3.12.1 Rest of the World Antibody-drug Conjugates Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Antibody-drug Conjugates Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Antibody-drug Conjugates Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Antibody-drug Conjugates Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Antibody-drug Conjugates Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Antibody-drug Conjugates Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Antibody-drug Conjugates Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Antibody-drug Conjugates Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Antibody-drug Conjugates Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Antibody-drug Conjugates Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Antibody-drug Conjugates Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Antibody-drug Conjugates Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Antibody-drug Conjugates Sales Volume Market Share by Type (2015-2020)
14.2 Global Antibody-drug Conjugates Sales Revenue Market Share by Type (2015-2020)
14.3 Global Antibody-drug Conjugates Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Antibody-drug Conjugates Consumption Volume by Application (2015-2020)
15.2 Global Antibody-drug Conjugates Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Antibody-drug Conjugates Business
16.1 ImmunoGen
16.1.1 ImmunoGen Company Profile
16.1.2 ImmunoGen Antibody-drug Conjugates Product Specification
16.1.3 ImmunoGen Antibody-drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Takeda
16.2.1 Takeda Company Profile
16.2.2 Takeda Antibody-drug Conjugates Product Specification
16.2.3 Takeda Antibody-drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Seattle Genetics
16.3.1 Seattle Genetics Company Profile
16.3.2 Seattle Genetics Antibody-drug Conjugates Product Specification
16.3.3 Seattle Genetics Antibody-drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Roche
16.4.1 Roche Company Profile
16.4.2 Roche Antibody-drug Conjugates Product Specification
16.4.3 Roche Antibody-drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Antibody-drug Conjugates Manufacturing Cost Analysis
17.1 Antibody-drug Conjugates Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Antibody-drug Conjugates
17.4 Antibody-drug Conjugates Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Antibody-drug Conjugates Distributors List
18.3 Antibody-drug Conjugates Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Antibody-drug Conjugates (2021-2026)
20.2 Global Forecasted Revenue of Antibody-drug Conjugates (2021-2026)
20.3 Global Forecasted Price of Antibody-drug Conjugates (2015-2026)
20.4 Global Forecasted Production of Antibody-drug Conjugates by Region (2021-2026)
20.4.1 North America Antibody-drug Conjugates Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Antibody-drug Conjugates Production, Revenue Forecast (2021-2026)
20.4.3 Europe Antibody-drug Conjugates Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Antibody-drug Conjugates Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Antibody-drug Conjugates Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Antibody-drug Conjugates Production, Revenue Forecast (2021-2026)
20.4.7 Africa Antibody-drug Conjugates Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Antibody-drug Conjugates Production, Revenue Forecast (2021-2026)
20.4.9 South America Antibody-drug Conjugates Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Antibody-drug Conjugates Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Antibody-drug Conjugates by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Antibody-drug Conjugates by Country
21.2 East Asia Market Forecasted Consumption of Antibody-drug Conjugates by Country
21.3 Europe Market Forecasted Consumption of Antibody-drug Conjugates by Countriy
21.4 South Asia Forecasted Consumption of Antibody-drug Conjugates by Country
21.5 Southeast Asia Forecasted Consumption of Antibody-drug Conjugates by Country
21.6 Middle East Forecasted Consumption of Antibody-drug Conjugates by Country
21.7 Africa Forecasted Consumption of Antibody-drug Conjugates by Country
21.8 Oceania Forecasted Consumption of Antibody-drug Conjugates by Country
21.9 South America Forecasted Consumption of Antibody-drug Conjugates by Country
21.10 Rest of the world Forecasted Consumption of Antibody-drug Conjugates by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer